Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer
Clinical trial NCT02560636 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02560636
- Sponsor
- Royal Marsden NHS Foundation Trust
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-06
- Primary completion
- 2025-01-15
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.